FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1
Journal of Clinical Investigation · 02.10.2023 · 133 (19)
DOI: 10.1172/jci160517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.10.2023. Verfasst von Chuandi Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye D…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Vascular Diseases. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project of China, National Natural Science Foundation of China, Shanghai Science and Technology Development Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Endothelial dysfunction is a critical and initiating factor of the vascular complications of diabetes. Inflammation plays an important role in endothelial dysfunction regulated by epigenetic modifications. N6-methyladenosine (m6A) is one of the most prevalent epigenetic modifications in eukaryotic cells. In this research, we identified an m6A demethylase, fat mass and obesity-associated protein (FTO), as an essential epitranscriptomic regulator in diabetes-induced vascular endothelial dysfunction. We showed that enhanced FTO reduced the global level of m6A in hyperglycemia. FTO knockdown in endothelial cells (ECs) resulted in less inflammation and compromised ability of migration and tube formation. Compared with EC Ftofl/fl diabetic mice, EC-specific Fto-deficient (EC FtoΔ/Δ) diabetic mice displayed less retinal vascular leakage and acellular capillary formation. Furthermore, methylated RNA immunoprecipitation sequencing (MeRIP-Seq) combined with RNA-Seq indicated that Tnip1 served as a downstream target of FTO. Luciferase activity assays and RNA pull-down demonstrated that FTO repressed TNIP1 mRNA expression by erasing its m6A methylation. In addition, TNIP1 depletion activated NF-κB and other inflammatory factors, which aggravated retinal vascular leakage and acellular capillary formation, while sustained expression of Tnip1 by intravitreal injection of adeno-associated virus alleviated endothelial impairments. These findings suggest that the FTO-TNIP1-NF-κB network provides potential targets to treat diabetic vascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai E…
- Shanghai Eye Diseases Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai General Hospital, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, C…
- Department of Endocrinology and Metabolism, Shanghai 10th People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Förderung
- National Science and Technology Major Project of China
- National Natural Science Foundation of China
- Shanghai Science and Technology Development Foundation
- Shanghai Rising Stars of Medical Talent Youth Development Program
- Clinical Research Innovation Plan of Shanghai General Hospital
- Natural Science Foundation of Shanghai
Zitieren
APA
Zhou, C., She, X., Gu, C., Hu, Y., Ma, M., Qiu, Q., Sun, T., Xu, X., Chen, H., & Zheng, Z. (2023). FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. Journal of Clinical Investigation, 133(19). https://doi.org/10.1172/jci160517
Vancouver
Zhou C, She X, Gu C, Hu Y, Ma M, Qiu Q, et al. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. Journal of Clinical Investigation. 2023;133(19). doi:10.1172/jci160517
BibTeX
@article{Zhou2023,
author = {Zhou, Chuandi and She, Xinping and Gu, Chufeng and Hu, Yanan and Ma, Mingming and Qiu, Qinghua and Sun, Tao and Xu, Xun and Chen, Haibing and Zheng, Zhi},
title = {FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {19},
doi = {10.1172/jci160517}
}
EUVIMED